R&D Expenses: Research and development expenses for the quarter ended September 30, 2025, were $9.4 million, compared to $9.7 million for the quarter ended September 30, 2024. The expenses were ...

Omalizumab had the greatest risk for adverse effects and dupilumab had the most favorable safety profile among biologics for patients with asthma, according to an abstract presented at the CHEST ...

The adverse event of interest was TdP, and the drugs targeted were all registered and classified as “suspect,” “interacting,” or “concomitant drugs” in FAERS. The DDI signals were identified and ...

1 Radiation Oncology Center, Chongqing University Cancer Hospital, Chongqing, China 2 Health Management Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China ...

Abstract: With the growth of the healthcare consumer electronics market, the clinical trial industry is facing new opportunities and there is an increasing focus on safety to protect patients from ...

Immune checkpoint inhibitors (ICI) have had a dramatic effect on cancer outcomes with their use increasing as indications expand. Despite impressive efficacy across a range of tumour types, their role ...

This is read by an automated voice. Please report any issues or inconsistencies here. The Marine Corps said I-5 will remain open after Gov. Gavin Newsom raised concerns that Navy ships will fire live ...

The PGA Tour surprised many a few weeks ago when it announced the creation of a ninth signature event for next season, to be played at Trump National Doral in Miami, Florida. The event is back in the ...

Introduction: Ixekizumab is a biologic agent primarily indicated for the treatment of moderate to-severe plaque psoriasis. This study aimed to evaluate the post-marketing safety profile of ixekizumab ...